EcoDrugPlus

P2x Purinoceptor 4-Like

Ensembl ID : ENSECRG00000018054
Gene Symbol: LOC114669266
2 Cross references
193 Possible Orthologues:

Pim-1 Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSECRG00000012562
Gene Symbol: PIM1
3 Cross references
250 Possible Orthologues:

Rela Proto-Oncogene, Nf-Kb Subunit

Ensembl ID : ENSECRG00000000703
Gene Symbol: RELA
3 Cross references
202 Possible Orthologues:

Raf-1 Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSECRG00000020686
Gene Symbol: RAF1
3 Cross references
225 Possible Orthologues:

Rho Associated Coiled-Coil Containing Protein Kinase 1

Ensembl ID : ENSECRG00000005295
Gene Symbol: ROCK1
3 Cross references
212 Possible Orthologues:

Sem1 26s Proteasome Subunit

Ensembl ID : ENSECRG00000012771
Gene Symbol: SEM1
1 Cross references
156 Possible Orthologues:

Src Proto-Oncogene, Non-Receptor Tyrosine Kinase

Ensembl ID : ENSECRG00000012226
Gene Symbol: SRC
3 Cross references
261 Possible Orthologues:

Tek Receptor Tyrosine Kinase

Ensembl ID : ENSECRG00000008636
Gene Symbol: TEK
3 Cross references
166 Possible Orthologues:

Tgf-Beta Receptor Type-1-Like

Ensembl ID : ENSECRG00000004040
Gene Symbol: LOC114653642
3 Cross references
236 Possible Orthologues:

Ttk Protein Kinase

Ensembl ID : ENSECRG00000002360
Gene Symbol: TTK
3 Cross references
205 Possible Orthologues:

Udp-Glucose Ceramide Glucosyltransferase

Ensembl ID : ENSECRG00000016864
Gene Symbol: UGCG
3 Cross references
212 Possible Orthologues:

Wee1 G2 Checkpoint Kinase

Ensembl ID : ENSECRG00000012644
Gene Symbol: WEE1
3 Cross references
227 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).